Growth inhibitory effects of 3′-nitro-3-phenylamino nor-beta-lapachone against HL-60: A redox-dependent mechanism

AbstractIn this study, the cytotoxicity, genotoxicity and early ROS generation of 2,2-dimethyl-(3H)-3-(N-3′-nitrophenylamino)naphtho[1,2-b]furan-4,5-dione (QPhNO2) were investigated and compared with those of its precursor, nor-beta-lapachone (nor-beta), with the main goal of proposing a mechanism of antitumor action. The results were correlated with those obtained from electrochemical experiments held in protic (acetate buffer pH 4.5) and aprotic (DMF/TBABF4) media in the presence and absence of oxygen and with those from dsDNA biosensors and ssDNA in solution, which provided evidence of a positive interaction with DNA in the case of QPhNO2. QPhNO2 caused DNA fragmentation and mitochondrial depolarization and induced apoptosis/necrosis in HL-60 cells. Pre-treatment with N-acetyl-l-cysteine partially abolished the observed effects related to the QPhNO2 treatment, including those involving apoptosis induction, indicating a partially redox-dependent mechanism. These findings point to the potential use of the combination of pharmacology and electrochemistry in medicinal chemistry

A century of trends in adult human height

Being taller is associated with enhanced longevity, and higher education and earnings. We reanalysed 1472 population-based studies, with measurement of height on more than 18.6 million participants to estimate mean height for people born between 1896 and 1996 in 200 countries. The largest gain in adult height over the past century has occurred in South Korean women and Iranian men, who became 20.2 cm (95% credible interval 17.5-22.7) and 16.5 cm (13.3-19.7) taller, respectively. In contrast, there was little change in adult height in some sub-Saharan African countries and in South Asia over the century of analysis. The tallest people over these 100 years are men born in the Netherlands in the last quarter of 20th century, whose average heights surpassed 182.5 cm, and the shortest were women born in Guatemala in 1896 (140.3 cm; 135.8-144.8). The height differential between the tallest and shortest populations was 19-20 cm a century ago, and has remained the same for women and increased for men a century later despite substantial changes in the ranking of countries

Rising rural body-mass index is the main driver of the global obesity epidemic in adults

Body-mass index (BMI) has increased steadily in most countries in parallel with a rise in the proportion of the population who live in cities 1,2 . This has led to a widely reported view that urbanization is one of the most important drivers of the global rise in obesity 3�6 . Here we use 2,009 population-based studies, with measurements of height and weight in more than 112 million adults, to report national, regional and global trends in mean BMI segregated by place of residence (a rural or urban area) from 1985 to 2017. We show that, contrary to the dominant paradigm, more than 55 of the global rise in mean BMI from 1985 to 2017�and more than 80 in some low- and middle-income regions�was due to increases in BMI in rural areas. This large contribution stems from the fact that, with the exception of women in sub-Saharan Africa, BMI is increasing at the same rate or faster in rural areas than in cities in low- and middle-income regions. These trends have in turn resulted in a closing�and in some countries reversal�of the gap in BMI between urban and rural areas in low- and middle-income countries, especially for women. In high-income and industrialized countries, we noted a persistently higher rural BMI, especially for women. There is an urgent need for an integrated approach to rural nutrition that enhances financial and physical access to healthy foods, to avoid replacing the rural undernutrition disadvantage in poor countries with a more general malnutrition disadvantage that entails excessive consumption of low-quality calories. © 2019, The Author(s)

Toxicity to sea urchin egg development of the quinone fraction obtained from Auxemma oncocalyx

Auxemma oncocalyx Taub. belongs to the Boraginaceae family and is native to the Brazilian northeast where it is known as "pau-branco". We investigated the ability of the water soluble fraction isolated from the heartwood of A. oncocalyx to inhibit sea urchin egg development. This fraction contains about 80% oncocalyxone A (quinone fraction), a compound known to possess strong cytotoxic and antitumor activities. In fact, the quinone fraction inhibited cleavage in a dose-dependent manner [IC50 of 18.4 (12.4-27.2) µg/ml, N = 6], and destroyed the embryos in the blastula stage [IC50 of 16.2 (13.7-19.2) µg/ml, N = 6]. We suggest that this activity is due to the presence of oncocalyxone A. In fact, these quinones present in A. oncocalyx extract have strong toxicity related to their antimitotic activity

Growth Inhibitory Effects Of 3'-nitro-3-phenylamino Nor-beta-lapachone Against Hl-60: A Redox-dependent Mechanism

In this study, the cytotoxicity, genotoxicity and early ROS generation of 2,2-dimethyl-(3H)-3-(N-3'-nitrophenylamino)naphtho[1,2-b]furan-4,5-dione (QPhNO 2) were investigated and compared with those of its precursor, nor-beta-lapachone (nor-beta), with the main goal of proposing a mechanism of antitumor action. The results were correlated with those obtained from electrochemical experiments held in protic (acetate buffer pH 4.5) and aprotic (DMF/TBABF 4) media in the presence and absence of oxygen and with those from dsDNA biosensors and ssDNA in solution, which provided evidence of a positive interaction with DNA in the case of QPhNO 2. QPhNO 2 caused DNA fragmentation and mitochondrial depolarization and induced apoptosis/necrosis in HL-60 cells. Pre-treatment with N-acetyl-l-cysteine partially abolished the observed effects related to the QPhNO 2 treatment, including those involving apoptosis induction, indicating a partially redox-dependent mechanism. These findings point to the potential use of the combination of pharmacology and electrochemistry in medicinal chemistry. © 2012 Elsevier Ltd.264585594Asche, C., Antitumour quinones (2005) Mini-Rev. Med. Chem., 5, pp. 449-467Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidmann, J.G., Struhl, K., (1990) Current Protocols in Molecular Biology, 2. , John Wiley & Sons, Inc., New YorkBova, M.P., Mattson, M.N., Vasile, S., Tam, D., Holsinge, L., Bremer, M., Hui, T., Fukuto, J.M., The oxidative mechanism of action of ortho-quinone inhibitors of protein-tyrosine phosphatase alpha is mediated by hydrogen peroxide (2004) Arch. Biochem. Biophys., 429, pp. 30-41Brett, A.M.O., Goulart, M.O.F., de Abreu, F.C., Reduction of lapachones and their reaction with L-cysteine and mercaptoethanol on glassy carbon electrodes (2002) Bioelectrochemistry, 56, pp. 53-55Cavalcanti, J.C.M., Oliveira, N.V., de Moura, M.A.B.F., Chaves, J.B., Alves, R.J., de Abreu, F.C., Goulart, M.O.F., Effect of the leaving group on the electrodic reduction mechanism of anti-Helicobacter pylori metronidazole derivatives, in aprotic and protic media (2004) Bioelectrochemistry, 63, pp. 353-357Cavalcanti, B.C., Barros, F.W.A., Cabral, I.O., Ferreira, J.R.O., Magalhães, H.I.F., Júnior, H.V.N., da Silva Júnior, E.N., Pessoa, C., Preclinical genotoxicology of nor-β-lapachone in human cultured lymphocytes and Chinese hamster lung fibroblasts (2011) Chem. Res. Toxicol., 24, pp. 1560-1574da Silva Júnior, E.N., de Souza, M.C.B.V., Pinto, A.V., Pinto, M.C.F.R., Goulart, M.O.F., Barros, F.W.A., Pessoa, C., Ferreira, V.F., Synthesis and potent antitumor activity of new arylamino derivatives of nor-β-lapachone and nor-α-lapachone (2007) Bioorg. Med. Chem., 15, pp. 7035-7041da Silva Júnior, E.N., Moura, M.A.B.F., Pinto, A.V., Pinto, M.C.F.R., de Souza, M.C.B.V., Araújo, A.J., Pessoa, C., Goulart, M.O.F., Cytotoxic, trypanocidal activities and physicochemical parameters of nor-β-lapachone-based 1,2,3-triazoles (2009) J. Braz. Chem. Soc., 20, pp. 635-643da Silva Júnior, E.N., de Deus, C.F., Martins, J.B.L., Lima, A.B., Cavalcanti, B.C., Pessoa, C., Costa-Lotufo, L.V., Pinto, A.V., 3-Arylamino and 3-alkoxy-nor-β-lapachone derivatives: synthesis and cytotoxicity against cancer cell lines (2010) J. Med. Chem., 53, pp. 504-508Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, M., Hotz, M.A., Lassota, P., Traganos, F., Features of apoptotic cells measured by flow cytometry (1992) Cytometry, 13, pp. 795-808de Abreu, F.C., Ferraz, P.A.M., Goulart, M.O.F., Some applications of electrochemistry in biomedical chemistry. Emphasis on the correlation of electrochemical and bioactive properties (2002) J. Braz. Chem. Soc., 13, pp. 19-35de Abreu, F.C., Goulart, M.O.F., Brett, A.M.O., Reduction of lapachones in aqueous media at a glassy carbon electrode (2002) Electroanalysis, 14, pp. 29-34de Abreu, F.C., Ferreira, D.C.M., Goulart, M.O.F., Buriez, O., Amatore, C., Electrochemical activation of beta-lapachone in beta-cyclodextrin inclusion complexes and reactivity of its reduced form towards oxygen in aqueous solutions (2007) J. Electroanal. Chem., 608, pp. 125-132de Abreu, F.C., de Paula, F.S., Ferreira, D.C.M., Nascimento, V.B., Santos, A.M.C., Santoro, M., Salas, C.E., Goulart, M.O.F., The application of DNA-biosensors and differential scanning calorimetry to the study of the DNA-binding agent berenil (2008) Sensors, 8, pp. 1519-1538de Souza, A.A., de Moura, M.A.B.F., de Abreu, F.C., Goulart, M.O.F., da Silva Júnior, E.N., Pinto, A.V., Ferreira, V.F., Squella, J.A., Electrochemical study, on mercury, of a meta-nitroarylamine derivative of nor-β-lapachone, an antitumor and trypanocidal compound (2010) Quim. Nova, 33, pp. 2075-2079Diculescu, V.C., Paquim, A.M.C., Brett, A.M.O., Electrochemical DNA sensors for detection of DNA damage (2005) Sensors, 5, pp. 377-393Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., Nagata, S., A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD (1998) Nature, 391, pp. 43-50Eskes, R., Desagher, S., Antonsson, B., Martinou, J.C., Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane (2000) Mol. Cell Biol., 20, pp. 929-935Ferreira, D.C.M., Tapsoba, I., Arbault, S., Bouret, Y., Alexandre Moreira, M.S., Pinto, A.V., Goulart, M.O.F., Amatore, C., Ex vivo activities of β-lapachone and α-lapachone on macrophages: a quantitative pharmacological analysis based on amperometric monitoring of oxidative bursts by single cells (2009) ChemBioChem, 10, pp. 528-538Foye, W.O., (1995) Cancer Chemotherapeutic Agents, , American Chemical Society, Washington, D.CGoulart, M.O.F., Ossowski, T., Pipka, P., Liwo, A., Electrochemical study of oxygen interaction with lapachol and its radical anions (2003) Bioelectrochemistry, 59, pp. 85-87Goulart, M.O.F., Lima, N.M.F., Santana, A.E.G., Ferraz, P.A.L., Cavalcanti, J.C.M., Liwo, A., Falkowsky, P., Ossowsky, T., Electrochemical studies of isolapachol with emphasis on oxygen interaction with its radical anions (2004) J. Electroanal. Chem., 566, pp. 25-29Goulart, M.O.F., de Souza, A.A., de Abreu, F.C., de Paula, F.S., Sales, E.M., Almeida, W.P., Buriez, O., Amatore, C., Electrochemical study of methyl 2-[p-nitrophenyl(hydroxy)methyl]acrylate (2007) J. Electrochem. Soc., 154, pp. 121-129Gupta, D., Podar, K., Tai, Y.T., Lin, B., Hideshima, T., Akiyama, M., LeBlanc, R., Anderson, K.C., Beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells (2002) Exp. Hematol., 30, pp. 711-720Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70Hernández, D.M., de Moura, M.A.B.F., Valencia, D.P., González, F.J., González, I., de Abreu, F.C., da Silva Júnior, E.N., Frontana, C., Inner reorganization during the radical-biradical transition in a nor-beta-lapachone derivative possessing two redox centers (2008) Org. Biomol. Chem., 6, pp. 3414-3420Hileman, E.O., Liu, J., Albitar, M., Keateng, M.J., Huang, P., Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity (2004) Cancer Chemother. Pharmacol., 53, pp. 209-219Hillard, E.A., de Abreu, F.C., Ferreira, D.C.M., Jaouen, G., Goulart, M.O.F., Amatore, C., Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds (2008) Chem. Commun., pp. 2612-2628Kerr, J.F.R., Wyllie, A.H., Currie, A.R., Apoptosis-Basic biological phenomenon with wide-ranging implications in tissue kinetics (1972) Brit. J. Cancer, 26, pp. 239-257Lebel, C.P., Ischiropoulos, H., Bondy, S.C., Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress (1992) Chem. Res. Toxicol., 5, pp. 227-231Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., Wang, X., Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade (1997) Cell, 91, pp. 479-489Melino, G., The Sirens' song (2001) Nature, 412, p. 23Mizutani, H., Tada-Oikawa, S., Hiraku, Y., Oikawa, S., Kojima, M., Kawanishi, S., Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide (2002) J. Biol. Chem., 277, pp. 30684-30689Montenegro, R.C., Araújo, A.J., Molina, M.T., Marinho-Filho, J.D.B., Rocha, D.D., Lopez-Montero, E., Goulart, M.O.F., Costa-Lotufo, L.V., Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-O-methyl derivative (2010) Chem. Biol. Interact., 184, pp. 439-448Mosmann, T., Rapid colorimetric assay for cellular growth and survival application to proliferation and cyto-toxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63Okada, H., Mak, T.W., Pathways of apoptotic and non-apoptotic death in tumour cells (2004) Nat. Rev. Cancer, 4, pp. 592-603Oliveira-Brett, A.M., Vivan, M., Fernandes, I.R., Piedade, J.A.P., Electrochemical detection of in situ adriamycin oxidative damage to DNA (2002) Talanta, 56, pp. 959-970Ossowski, T., Pipka, P., Liwo, A., Jeziorek, D., Electrochemical and UV-spectrophotometric study of oxygen and superoxide anion radical interaction with anthraquinone derivatives and their radical anions (2000) Electrochim. Acta, 45, pp. 3581-3587Ozben, T., Oxidative stress and apoptosis: impact on cancer therapy (2007) J. Pharm. Sci., 96, pp. 2181-2196Piedade, J.A.P., Fernandez, I.R., Brett, A.M.O., Electrochemical sensing of DNA-adriamycin interactions (2002) Bioelectrochemistry, 56, pp. 81-83Planchon, S.M., Wuerzberger, S., Frydman, B., Witiak, D.T., Hutson, P., Church, D.R., Wilding, G., Boothman, D.A., β-Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response (1995) Cancer Res., 55, pp. 3706-3711Planchon, S.M., Wuerzberger-Davis, S.M., Pink, J.J., Robertson, K.A., Bornmann, W.G., Boothman, D.A., Bcl-2 protects against beta-lapachone-mediated caspase 3 activation and apoptosis in human myeloid leukemia (HL-60) cells (1999) Oncol Rep., 6, pp. 485-492Rauf, S., Gooding, J.J., Akhtar, K., Ghauri, M.A., Rahman, M., Anwar, M.A., Khalid, A.M., Electrochemical approach of anticancer drugs - DNA interaction (2005) J. Pharm. Biomed. Anal., 37, pp. 205-217Singh, N.P., McCoy, M.T., Tice, R.R., Schneider, E.L., A simple technique for quantitation of low-levels of DNA damage in individual cells (1988) Exp. Cell Res., 175, pp. 184-191Wang, J., Ozsoz, M., Cai, X.H., Rivas, G., Shiraishi, H., Grant, D.H., Chicharro, M., Palecek, E., Interactions of antitumor drug daunomycin with DNA in solution and at the surface (1998) Bioelectrochem. Bioenerg., 45 (1998), pp. 33-40Zafarullaha, M., Lia, W.Q., Sylvestera, J., Ahmad, M., Molecular mechanisms of N-acetylcysteine actions (2003) Cell. Mol. Life Sci., 60, pp. 6-20Ziegler, U., Groscurth, P., Morphological features of cell death (2004) News Physiol. Sci., 19, pp. 124-12

Evaluation of the cholinomimetic actions of trimethylsulfonium, a compound present in the midgut gland of the sea hare Aplysia brasiliana (Gastropoda, Opisthobranchia)

Trimethylsulfonium, a compound present in the midgut gland of the sea hare Aplysia brasiliana, negatively modulates vagal response, indicating a probable ability to inhibit cholinergic responses. In the present study, the pharmacological profile of trimethylsulfonium was characterized on muscarinic and nicotinic acetylcholine receptors. In rat jejunum the contractile response induced by trimethylsulfonium (pD2 = 2.46 ± 0.12 and maximal response = 2.14 ± 0.32 g) was not antagonized competitively by atropine. The maximal response (Emax) to trimethylsulfonium was diminished in the presence of increasing doses of atropine (P<0.05), suggesting that trimethylsulfonium-induced contraction was not related to muscarinic stimulation, but might be caused by acetylcholine release due to presynaptic stimulation. Trimethylsulfonium displaced [³H]-quinuclidinyl benzilate from rat cortex membranes with a low affinity (Ki = 0.5 mM). Furthermore, it caused contraction of frog rectus abdominis muscles (pD2 = 2.70 ± 0.06 and Emax = 4.16 ± 0.9 g), which was competitively antagonized by d-tubocurarine (1, 3 or 10 µM) with a pA2 of 5.79, suggesting a positive interaction with nicotinic receptors. In fact, trimethylsulfonium displaced [³H]-nicotine from rat diaphragm muscle membranes with a Ki of 27.1 µM. These results suggest that trimethylsulfonium acts as an agonist on nicotinic receptors, and thus contracts frog skeletal rectus abdominis muscle and rat jejunum smooth muscle via stimulation of postjunctional and neuronal prejunctional nicotinic cholinoreceptors, respectively